Becker's Healthcare December 30, 2024
Elizabeth Gregerson

What remains after the passing of former President Jimmy Carter encompasses more than politics and humanitarianism, it also includes cancer care, according to a Dec. 29 NBC News report.

Diagnosed with metastatic melanoma in 2015 at the age of 90, Mr. Carter was one of the first public figures to speak openly about immunotherapy. He was treated with the drug pembrolizumab, relatively new at the time and sold as Keytruda, the report said.

Mr. Carter’s willingness to talk about immunotherapy increased attention and interest in the growing field, Amod Sarnaik, MD, professor of cutaneous oncology and immunology at Tampa, Fla.-based Moffitt Cancer Center, told NBC News.

Suresh Ramalingam, MD, executive director of Atlanta-based Emory University’s Winship Cancer...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Patient / Consumer, Provider
Biden administration launches cybersecurity executive order
Healthcare in the Mix in President Biden's Farewell Address
Congress and health care in 2025: Disrupting the status quo, and vaccine skepticism
Trump's plans for HHS: 13 knowns
How Tariffs Could Wreak Havoc on Health Care Costs and Supply Chains in the U.S.

Share This Article